Newton Biocapital’s first fund was instrumental in establishing four spinouts and it has raised $57m towards its $172m goal for its second vehicle.

University of Tokyo’s venture arm has reached a final close for its second fund thanks to commitments from 11 institutional investors including the institution itself.

Orange Grove Bio has partnered SV Investment to jointly source therapeutics in South Korea and the US and create spinouts.

Milo Werner has joined The Engine as general partner as the MIT-founded venture firm confirmed its second fund has reached $302m.

The venture fund officially launched at the end of last month, having already invested in five companies linked to University of Washington.

The CSIRO-linked venture firm has obtained additional capital from the Australian government less than a year after launching its second fund with an initial $194m.

The newly launched investment company will exclusively co-invest in spinouts from UCPH.

Porter Alliance for Innovative Medicines will be equipped with $130m to advance research from Stanford’s Innovative Medicines Accelerator.

Nestlé is throwing its weight behind the Eureka Fund, a vehicle focused on spinouts from 27 research centres and universities across Italy.

Three years after its launch, Tel Aviv University-linked TAU Ventures has raised $50m for its second fund, with the potential to increase it to $70m.